Comenzó estudio para completar el desarrollo de vacuna tetravalente contra la influenza

The development of a tetravalent flu vaccine has begun, according to a recent article. This new vaccine is designed to combat four strains of the influenza virus. Currently, the most widely available flu vaccine is only able to protect against three strains. The study is being conducted by several institutions across various countries, including the United States, the United Kingdom, and Australia. During a clinical trial, participants will be given two doses of the vaccine, which will then be evaluated for safety and efficacy. If successful, the tetravalent flu vaccine could potentially prevent more cases of the flu each year. The study is exciting news for those who worry about the spread of influenza, as it could bring us one step closer to a world in which widespread outbreaks are prevented.